Keyphrases
Maastricht
100%
Negatively Associated
100%
Flow Motion
100%
Hyperglycemia
100%
Type 2 Diabetes Mellitus (T2DM)
25%
Pre-diabetes (pre-DM)
25%
Hemoglobin A1c (HbA1c)
16%
Diabetes
16%
Fasting Plasma Glucose
16%
Post-load Glucose
16%
Laser Doppler Flowmetry
16%
Myogenic
16%
Conservative Model
8%
Linear Regression Analysis
8%
Microvascular Vasomotion
8%
HbA1c Levels
8%
Diabetic Retinopathy
8%
Normal Glucose Tolerance
8%
Glucose Metabolism Status
8%
Trend Analysis
8%
Population-based Cohort
8%
Obesity
8%
Nutrient Delivery
8%
Functional Impairment
8%
Advanced Glycation End Products
8%
Continuous Glucose Monitoring
8%
Diabetic Nephropathy
8%
Oxygen Delivery
8%
Diabetic Neuropathy
8%
Vasomotion
8%
INIS
skin
100%
hyperglycemia
100%
glucose
81%
power
36%
diabetes mellitus
18%
fasting
18%
metabolism
18%
plasma
18%
populations
18%
data
18%
lasers
18%
nutrients
9%
monitoring
9%
adjustments
9%
metrics
9%
levels
9%
regression analysis
9%
obesity
9%
oxygen
9%
peaks
9%
delivery
9%
tissues
9%
Medicine and Dentistry
Hyperglycemia
100%
Hemoglobin A1c
42%
Impaired Glucose Tolerance
42%
Laser Doppler Flowmetry
28%
Glucose Metabolism
28%
Diabetes
28%
Vasomotion
28%
Maturity Onset Diabetes of the Young
28%
Glucose Test
28%
Diabetic Nephropathy
14%
Advanced Glycation End-Product
14%
Microcirculation
14%
Vascular Resistance
14%
Ligation
14%
Type 2 Diabetes
14%
Autofluorescence
14%
Diabetic Neuropathy
14%
Microvascular Complication
14%
Diabetic Retinopathy
14%
Linear Regression Analysis
14%
